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S U M M A R Y
We report three consecutive cases of tularemia occurring in Burgundy, France, a region previously
considered not endemic for tularemia. The patients presented with varied and unspeciﬁc clinical
manifestations. The epidemiological circumstances, especially the mode of contamination, were not
particularly suggestive of tularemia. Serological diagnosis was delayed in two cases because of the lack of
signiﬁcant antibody titers at the time of admission. In contrast, a diagnosis could readily be obtained in
all three cases by detection of Francisella tularensis DNA from clinical samples using PCR-based methods.
These cases highlight the increased incidence and geographical spread of tularemia in France, and the
usefulness of real-time PCR technology for the early diagnostic conﬁrmation of tularemia.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Tularemia is considered an emerging disease in France. We
report three recent cases occurring in Burgundy, a region
previously considered as not endemic for tularemia. The absence
of clinical and epidemiological ﬁndings suggestive of tularemia led
to diagnostic wanderings. Our goal is to emphasize that tularemia
should be systematically considered in patients with compatible
clinical presentations, including in areas where the disease is
considered uncommon. PCR-based techniques may be useful to
conﬁrm the diagnosis in such difﬁcult situations.
2. Case reports
2.1. Patient 1
A 36-year-old man presented with intermittent fever, profuse
sweating, cough evolving over 3 weeks, and deterioration of his
general status. A computed tomography scan found a mediastinal
inﬁltration and a right hilar lymphadenopathy. Biological inves-
tigations showed a lymphocytosis (9  109/l) and an increased C-
reactive protein level (50 mg/l). Routine examination of a
bronchoalveolar lavage ﬂuid sample and a bone marrow biopsy
were unrevealing. Pathological examination of mediastinal tissue
biopsies corresponded to a lymphadenitis with epithelioid and* Corresponding author. Tel.: +33 4 76 76 54 79; fax: +33 4 76 76 52 28.
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interferon-gamma release assay (Quantiferon1TB Gold; Cellestis
GmbH, Hannover, Germany) were negative. Serological tests for
HIV, Epstein–Barr virus, cytomegalovirus, and Bartonella henselae
were negative. In contrast, Francisella tularensis serology was
positive with IgM and IgG titers of 1:320 and 1:640, respectively
(immunoﬂuorescence test, cut-off titers of 1:160). F. tularensis DNA
was detected in the mediastinal lymph node tissue using a real-
time PCR test targeting the insertion sequence Ftu2 (rtPCR-ISFtu2).
The patient lived in a rural area, and was regularly exposed to a
ﬁeld where many wild rabbits live. His condition improved rapidly
on ﬂuoroquinolone therapy.
2.2. Patient 2
A 42-year-old woman was referred to our hospital because of a
suspicion of ethmoiditis and persistent fever despite administration
of pristinamycin and steroids. On admission, she presented
symptoms compatible with Parinaud’s oculoglandular syndrome,
including a fever, purulent conjunctivitis of the left eye, and enlarged
homolateral preauricular and jugular lymph nodes. The preauricular
lymphadenopathy had evolved to suppuration. Serological tests for
B. henselae and F. tularensis were negative. However, an rtPCR-ISFtu2
test performed on preauricular lymph node suppuration obtained by
needle aspiration was positive. Seroconversion to F. tularensis
antigen was detected 3 weeks later (IgM and IgG titers of 1:320).
Doxycycline administration resulted in rapid clinical improvement,
but the preauricular lymphadenopathy had to be surgically removed
because of skin ﬁstulization. F. tularensis subsp. holarctica DNA wasses. Published by Elsevier Ltd. All rights reserved.
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ampliﬁcation and sequencing of the 16S-23SrRNA intergenic spacer
region (ITS). The patient had carried dead wood 1 week before the
beginning of her symptoms, and we suspected a self-inoculation
through contaminated ﬁngers.
2.3. Patient 3
A 48-year-old female patient presented with high-grade fever
(40 8C) and severe headaches. The day before, she had noticed
about 20 skin lesions on both upper limbs that she related to
multiple tick bites sustained while she was collecting dead wood in
a forest. Examination revealed multiple black eschars, and
bilateral, small, and painful axillary lymph nodes. Tularemia
serology was negative. An rtPCR-ISFtu2 test performed on a skin
eschar biopsy was positive. Seroconversion to F. tularensis antigen
was detected 2 weeks later (IgM and IgG titers of 1:160). The
patient became afebrile within 48 h of ﬂuoroquinolone treatment.
3. Discussion
Human tularemia is a zoonosis caused by Francisella tularensis (a
potential bioterrorism agent), including subspecies holarctica in the
whole northern hemisphere and subspecies tularensis in North
America.1,2 A re-emergence of the disease has been reported
worldwide during the last decade.1,3 In France, the observed
incidence has increased from 2003 to the present day, and there
was an alarming peak in 2008. Moreover, many cases are now
acquired in regions outside traditional endemic areas. As an
example, while Burgundy was considered a region almost free of
tularemia until 2006, autochthonous cases are now commonly
reported.
The most important natural reservoir of F. tularensis is probably
represented by small rodents, lagomorphs (hares, rabbits), and
arthropods (especially ticks).1,3 Humans are usually contaminated
through direct contact with or ingestion of infected animals or
through arthropod farmers, and forest walkers are examples of
potentially exposed persons. Although the case of patient 3
corresponded to a tick-borne infection, the presence of multiple
cutaneous eschars was quite unusual. As for the two other patients,
the source of the infection remains hypothetical, but could
correspond to environmental exposure.1
The clinical manifestations of tularemia are varied and primarily
depend on the route of infection.3 Most patients suffer from a
regional lymphadenopathy after skin inoculation of bacteria, with or
without a detectable cutaneous inoculation lesion (ulceroglandular
and glandular forms, respectively). Other clinical forms are rarer and
more difﬁcult to diagnose: the oculoglandular form after conjuncti-
val inoculation, the oropharyngeal form after contamination by theoral route, the pneumonic form after inhalation of infected aerosols
or as a consequence of bacteremia, and the typhoidal form, a severe
systemic infection with prostration. The three reported cases
presented with unusual and unspeciﬁc clinical ﬁndings that could
evoke a large number of infectious (e.g., tuberculosis, cat-scratch
disease, toxoplasmosis, herpes simplex virus, cytomegalovirus,
Epstein–Barr virus, etc.) and non-infectious diseases (e.g., lympho-
ma).
The diagnosis of tularemia is usually conﬁrmed by serological
tests,4 but these can be misleading because of delayed onset of
signiﬁcant antibody titers and, occasionally, false-positive results
due to serological cross-reactions. These tests were negative at the
time of admission for two patients (patients 2 and 3), who
presented with acute clinical manifestations a few days after
contamination. Although seroconversion could be demonstrated
2–3 weeks later in both patients, early diagnostic conﬁrmation was
obtained using a previously described real-time PCR test.5
Altogether, PCR tests were positive in all three patients and four
clinical samples. Interestingly, for patient 1, F. tularensis DNA could
be ampliﬁed from parafﬁn-embedded mediastinal lymph node
tissue. F. tularensis subsp. holarctica could be identiﬁed in one
patient by ITS ampliﬁcation and sequencing directly from lymph
node tissue.5 Subspecies identiﬁcation is of primary importance in
the context of biothreat surveillance.
In conclusion, tularemia is an emerging disease in France and
particularly in the Burgundy region. Early diagnosis and treatment
of tularemia cases are necessary to avoid unnecessary etiological
investigations and to prevent complications. Real-time PCR tests
may help to establish the diagnosis of tularemia, especially in the
early phase of the disease and/or in patients with an unusual
clinical and epidemiological presentation.
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